We have located links that may give you full text access.
[Use of collagen-polyvinylpirrolidone in the treatment of Parry-Romberg syndrome.]
Revista Médica del Instituto Mexicano del Seguro Social 2013 November
Background: Parry-Romberg syndrome is characterized by the presence of progressive hemifacial atrophy that affects the growth and development of structures on one side of the face. Our objective was to introduce collagen-polyvinylpirrolidone as a new therapeutic option for Parry-Romberg syndrome in two clinical cases. Clinical cases: two women, aging 56 and 28 years old, with facial hypocrhomic lesions, and right and left fronto-malar sunken area respectively, treated with topic steroids + penicilamina, fat grafts and silicone implants without improvement. We used collagen-polyvinylpirrolidone and they showed improvement: after six months there were not clinical or esthetical complications. Conclusions: collagen-polivinilpirrolidone could be a new therapeutic option for Parry-Romberg syndrome with good clinical and esthetical results. It is easy to apply and it has few side effects and without complications.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app